Live register
Drugs in short supply
1,181 products are currently reported in shortage to the FDA. Each row links to the manufacturer’s entry, so you can see what else they make and where. Most recently updated first; page 1 of 5. What changed this week / How many companies make each one.
By therapeutic category
Anesthesia359
Pediatric282
Psychiatry262
Gastroenterology138
Analgesia/Addiction133
Neurology126
Endocrinology/Metabolism112
Other103
| Drug | Manufacturer | Presentation | Availability | Updated |
|---|---|---|---|---|
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01) | Available | 02 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01) | Available | 02 Oct 26 |
| Azacitidine Injection | Bristol Myers Squibb Co. | Vidaza, Injection, 100 mg (NDC 59572-102-01) | Available | 02 Oct 26 |
| Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Klonopin, Tablet, 1 mg (NDC 61269-610-10) | Available | 02 Oct 26 |
| Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Klonopin, Tablet, .5 mg (NDC 61269-605-10) | Available | 02 Oct 26 |
| Dexmedetomidine Hydrochloride Injection | Par Health, USA LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20) | Unavailable | 02 Oct 26 |
| Dexmedetomidine Hydrochloride Injection | Par Health, USA LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10) | Unavailable | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) | Limited Availability | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) | Available | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) | Limited Availability | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) | Available | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) | Available | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) | Limited Availability | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) | Available | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) | Limited Availability | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) | Available | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) | Available | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) | Limited Availability | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) | Limited Availability | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) | Limited Availability | 02 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Alvogen | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) | Available | 02 Oct 26 |
| Methylprednisolone Acetate Injection | Par Health, USA LLC | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) | Unavailable | 02 Oct 26 |
| Amino Acid Injection | Otsuka ICU Medical LLC | Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17) | Available | 01 Oct 26 |
| Amino Acid Injection | Otsuka ICU Medical LLC | Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03) | Unavailable | 01 Oct 26 |
| Amino Acid Injection | Otsuka ICU Medical LLC | Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05) | Unavailable | 01 Oct 26 |
| Amino Acid Injection | Otsuka ICU Medical LLC | Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02) | Limited Availability | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01) | Unavailable | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sunrise Pharmaceutical, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01) | Available | 01 Oct 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37) | Available | 01 Oct 26 |
| Atropine Sulfate Injection | American Regent, Inc. | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) | Available | 01 Oct 26 |
| Atropine Sulfate Injection | American Regent, Inc. | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) | Available | 01 Oct 26 |
| Azacitidine Injection | Teva Pharmaceuticals USA, Inc. | Azacitidine, Injection, 100 mg (NDC 68001-313-56) | Unavailable | 01 Oct 26 |
| Carboplatin Injection | Teva Pharmaceuticals USA, Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01) | Unavailable | 01 Oct 26 |
| Carboplatin Injection | Teyro Labs | Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) | Unavailable | 01 Oct 26 |
| Carboplatin Injection | Teva Pharmaceuticals USA, Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01) | Limited Availability | 01 Oct 26 |
| Carboplatin Injection | Teyro Labs | Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) | Unavailable | 01 Oct 26 |
| Carboplatin Injection | Teyro Labs | Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) | Unavailable | 01 Oct 26 |
| Carboplatin Injection | Teyro Labs | Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) | Unavailable | 01 Oct 26 |
| Carboplatin Injection | Teva Pharmaceuticals USA, Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01) | Limited Availability | 01 Oct 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, 2 mg (NDC 0093-3213-01) | Available | 01 Oct 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, .5 mg (NDC 0093-0832-01) | Available | 01 Oct 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, 1 mg (NDC 0093-3212-05) | Available | 01 Oct 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, .5 mg (NDC 0093-0832-05) | Available | 01 Oct 26 |
| Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Clonazepam, Tablet, 2 mg (NDC 0093-3213-05) | Available | 01 Oct 26 |
| Dexmedetomidine Hydrochloride Injection | HQ Specialty Pharma | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04) | Available | 01 Oct 26 |
| Dexmedetomidine Hydrochloride Injection | HQ Specialty Pharma | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24) | Available | 01 Oct 26 |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) | Unavailable | 01 Oct 26 |
| Dexmedetomidine Hydrochloride Injection | HQ Specialty Pharma | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24) | Available | 01 Oct 26 |
| Dexmedetomidine Hydrochloride Injection | HQ Specialty Pharma | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04) | Available | 01 Oct 26 |
| Dextrose Monohydrate 10% Injection | Otsuka ICU Medical LLC | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19) | Unavailable | 01 Oct 26 |
| Dextrose Monohydrate 10% Injection | Otsuka ICU Medical LLC | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09) | Available | 01 Oct 26 |
| Dextrose Monohydrate 10% Injection | Otsuka ICU Medical LLC | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02) | Available | 01 Oct 26 |
| Dextrose Monohydrate 10% Injection | Otsuka ICU Medical LLC | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-36) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20) | Available | 01 Oct 26 |
| Dextrose Monohydrate 5% Injection | Otsuka ICU Medical LLC | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23) | Available | 01 Oct 26 |
| Dextrose Monohydrate 70% Injection | Otsuka ICU Medical LLC | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07) | Available | 01 Oct 26 |
| Dextrose Monohydrate 70% Injection | Otsuka ICU Medical LLC | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19) | Available | 01 Oct 26 |
| Hydromorphone Hydrochloride Injection | Teva Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) | Available | 01 Oct 26 |
| Hydromorphone Hydrochloride Injection | Teva Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) | Limited Availability | 01 Oct 26 |
| Hydromorphone Hydrochloride Injection | Teva Pharmaceuticals USA, Inc. | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) | Available | 01 Oct 26 |
| Hydroxocobalamin Injection | Teva Pharmaceuticals USA, Inc. | Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) | Unavailable | 01 Oct 26 |
| Hydroxocobalamin Injection | BTG International Inc. | Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) | Limited Availability | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) | Available | 01 Oct 26 |
| Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) | Available | 01 Oct 26 |
| Methotrexate Sodium Injection | Teva Pharmaceuticals USA, Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01) | Limited Availability | 01 Oct 26 |
| Methotrexate Sodium Injection | Teva Pharmaceuticals USA, Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01) | Limited Availability | 01 Oct 26 |
| Methotrexate Sodium Injection | Teva Pharmaceuticals USA, Inc. | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Lannett Company, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37) | Unavailable | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Lannett Company, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Teva Pharmaceuticals USA, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Lannett Company, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Vertical Pharmaceuticals, LLC | Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30) | Available | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Trigen Laboratories, LLC | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10) | Limited Availability | 01 Oct 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Lannett Company, Inc. | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37) | Unavailable | 01 Oct 26 |
| Midazolam Hydrochloride Injection | WG Critical Care | Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) | Available | 01 Oct 26 |
| Midazolam Hydrochloride Injection | WG Critical Care | Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) | Available | 01 Oct 26 |
| Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1) | Unavailable | 01 Oct 26 |
| Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) | Available | 01 Oct 26 |
| Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) | Available | 01 Oct 26 |
| Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) | Available | 01 Oct 26 |
| Sodium Acetate Injection | Milla Pharmaceuticals | Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) | Available | 01 Oct 26 |
| Sodium Acetate Injection | Milla Pharmaceuticals | Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) | Available | 01 Oct 26 |
| Sodium Acetate Injection | Milla Pharmaceuticals | Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) | Available | 01 Oct 26 |
| Sodium Acetate Injection | Milla Pharmaceuticals | Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) | Limited Availability | 01 Oct 26 |
| Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4) | Available | 01 Oct 26 |
| Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4) | Available | 01 Oct 26 |
| Sodium Bicarbonate Injection | Long Grove Pharmaceuticals LLC | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3) | Available | 01 Oct 26 |
| Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5) | Available | 01 Oct 26 |
| Sterile Water Irrigant | Otsuka ICU Medical LLC | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-09) | Unavailable | 01 Oct 26 |
| Sterile Water Irrigant | Otsuka ICU Medical LLC | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-22) | Unavailable | 01 Oct 26 |
| Sterile Water Irrigant | Otsuka ICU Medical LLC | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-03) | Unavailable | 01 Oct 26 |
| Sterile Water Irrigant | Otsuka ICU Medical LLC | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-36) | Unavailable | 01 Oct 26 |
| Technetium TC-99M Pyrophosphate Kit Injection | Curium US LLC | Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20) | Limited Availability | 01 Oct 26 |
| Cromolyn Sodium Concentrate | Ailex Pharmaceuticals | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96) | Limited Availability | 30 Sept 26 |
| Cromolyn Sodium Concentrate | Ailex Pharmaceuticals | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 81665-104-96) | Available | 30 Sept 26 |
| Cromolyn Sodium Concentrate | Ailex Pharmaceuticals | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 69784-200-96) | Limited Availability | 30 Sept 26 |
| Azacitidine Injection | Dr. Reddy's Laboratories, Inc. | Azacitidine, Injection, 100 mg (NDC 43598-305-62) | Available | 29 Sept 26 |
| Amino Acid Injection | B. Braun Medical Inc. | TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10) | Available | 22 Sept 26 |
| Amino Acid Injection | B. Braun Medical Inc. | Plenamine, Injection, 0.15 (NDC 0264-4500-05) | Available | 22 Sept 26 |
| Amino Acid Injection | B. Braun Medical Inc. | Plenamine, Injection, 0.15 (NDC 0264-4500-00) | Available | 22 Sept 26 |
| Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 225 mg/30 mL (NDC 0409-2253-25) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1530-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-2510-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01) | Limited Availability | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10) | Unavailable | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 250 mg/50 mL (NDC 0409-0525-25) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-7535-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Marcaine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-5010-01) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride and Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01) | Unavailable | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01) | Unavailable | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01) | Unavailable | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10) | Available | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride and Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17) | Unavailable | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01) | Unavailable | 22 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17) | Unavailable | 22 Sept 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05) | Unavailable | 22 Sept 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18) | Unavailable | 22 Sept 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18) | Limited Availability | 22 Sept 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50) | Limited Availability | 22 Sept 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22) | Limited Availability | 22 Sept 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05) | Unavailable | 22 Sept 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05) | Unavailable | 22 Sept 26 |
| Carboplatin Injection | Hospira, Inc., a Pfizer Company | Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56) | Limited Availability | 22 Sept 26 |
| Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20) | Available | 22 Sept 26 |
| Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10) | Available | 22 Sept 26 |
| Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00) | Available | 22 Sept 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20) | Available | 22 Sept 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32) | Available | 22 Sept 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31) | Available | 22 Sept 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10) | Available | 22 Sept 26 |
| Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00) | Available | 22 Sept 26 |
| Dextrose Monohydrate 50% Injection | Hospira, Inc., a Pfizer Company | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) | Available | 22 Sept 26 |
| Dextrose Monohydrate 70% Injection | B. Braun Medical Inc. | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50) | Available | 22 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10) | Available | 22 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1 mg/mL) (NDC 0409-0025-10) | Available | 22 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88) | Unavailable | 22 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01) | Available | 22 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02) | Available | 22 Sept 26 |
| Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10) | Available | 22 Sept 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Available | 22 Sept 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) | Available | 22 Sept 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) | Unavailable | 22 Sept 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12) | Available | 22 Sept 26 |
| Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12) | Available | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01) | Unavailable | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01) | Unavailable | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03) | Limited Availability | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01) | Available | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02) | Unavailable | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01) | Unavailable | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01) | Unavailable | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03) | Limited Availability | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01) | Available | 22 Sept 26 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02) | Limited Availability | 22 Sept 26 |
| Etomidate Injection | Hospira, Inc., a Pfizer Company | Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Available | 22 Sept 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) | Limited Availability | 22 Sept 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) | Limited Availability | 22 Sept 26 |
| Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Available | 22 Sept 26 |
For manufacturers
A shortage is a sourcing event.
Every product on this list is a molecule somebody urgently needs another source for. If you hold registered capacity for any of them, list it and we will route matching requests to you.
Provenance
Source: FDA drug shortage database via openFDA, refreshed daily. Note that the openFDA feed carries no reason-for-shortage field, so availability and therapeutic category are shown instead of a cause. Shortage status changes between refreshes; check the FDA database directly before acting on it clinically. This site is not affiliated with the FDA. Need shortage exposure joined to every NDC and manufacturer as a file? See the dataset.